Skip to Main Content
Try STAT+ TODAY
Trending:
Pharmalot
First Opinion
Health
Coronavirus
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Pharmalot
STAT+

Chinese ingredients maker plays hide and seek with FDA inspectors

  • Ed Silverman

By Ed Silverman Nov. 2, 2016

Reprints
FDA Securities Fraud
US FDA sent a warning letter to a Chinese pharma ingredient manufacturer for blocking inspections Andrew Harnik/AP

Drums? What drums?

Yet another foreign company tried to fool the US Food and Drug Administration, but without success.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Ed Silverman

Ed Silverman

Pharmalot Columnist, Senior Writer

Ed covers the pharmaceutical industry.

Tags

Risk of ‘brain fog’ and other conditions persists up…
Risk of ‘brain fog’ and other conditions persists up to two years after Covid infection
In an effort to address its missteps during Covid,…
In an effort to address its missteps during Covid, CDC plans an ‘ambitious’ agency overhaul
A complicated fall vaccine campaign: Updated Covid boosters, flu…
A complicated fall vaccine campaign: Updated Covid boosters, flu shots, and how to time the jabs
Medicare may eventually negotiate some drug prices, but Colorado…
Medicare may eventually negotiate some drug prices, but Colorado still wants to import medicines from Canada
Listen: Private equity in autism care, a watershed FDA…
Listen: Private equity in autism care, a watershed FDA approval, and the future of ALS treatment
Pharmalittle: FDA approves a gene therapy for a rare…
Pharmalittle: FDA approves a gene therapy for a rare blood disorder; pharmacy chains ordered to pay…

Recommended Stories